Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion type Assertion NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_head.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion description "[The production of IFN-? and TNF-? by CD4(+) and CD8(+) T lymphocytes from patients with lower-risk MDS could be enhanced by recombinant human IL-17 (rhIL-17) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_provenance.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion evidence source_evidence_literature NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_provenance.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion SIO_000772 23331180 NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_provenance.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion wasDerivedFrom befree-20140225 NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_provenance.
- NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_assertion wasGeneratedBy ECO_0000203 NP602462.RAvlBXKsPeL0hQflwyY46CO-_hYfEy0sVnP1nFjo5p7gE130_provenance.